Cargando…

Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial

BACKGROUND: Tacrolimus (TAC) to ciclosporin A (CSA) conversion studies in stable kidney transplant recipients have reported varying effects on graft function. Here we study graft function (eGFR) trajectories using linear mixed models, which provide effect estimates on both slope and baseline level o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plischke, Max, Riegersperger, Markus, Dunkler, Daniela, Heinze, Georg, Kikić, Željko, Winkelmayer, Wolfgang C., Sunder-Plassmann, Gere
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535983/ https://www.ncbi.nlm.nih.gov/pubmed/26270340 http://dx.doi.org/10.1371/journal.pone.0135674

Ejemplares similares

A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes
por: Riegersperger, Markus, et al.
Publicado: (2019)

Randomized, Single Blind, Controlled Trial to Evaluate the Prime-Boost Strategy for Pneumococcal Vaccination in Renal Transplant Recipients
por: Tobudic, Selma, et al.
Publicado: (2012)

Pulsed oral sirolimus in advanced autosomal-dominant polycystic kidney disease (Vienna RAP Study): study protocol for a randomized controlled trial
por: Riegersperger, Markus, et al.
Publicado: (2015)

Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study)
por: Gaggl, Martina, et al.
Publicado: (2013)

Augmented Backward Elimination: A Pragmatic and Purposeful Way to Develop Statistical Models
por: Dunkler, Daniela, et al.
Publicado: (2014)

Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2020)

Screening for Fabry Disease by Urinary Globotriaosylceramide Isoforms Measurement in Patients with Left Ventricular Hypertrophy
por: Gaggl, Martina, et al.
Publicado: (2016)

Explaining variability in ciclosporin exposure in adult kidney transplant recipients
por: Press, Rogier R., et al.
Publicado: (2010)

Pilot Analysis of Late Conversion to Belatacept in Kidney Transplant Recipients for Biopsy-Proven Chronic Tacrolimus Toxicity
por: Gupta, Shruti, et al.
Publicado: (2018)

Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant
por: Muduma, Gorden, et al.
Publicado: (2016)

Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method
por: Winnicki, Wolfgang, et al.
Publicado: (2019)

Systematic conversion to generic tacrolimus in stable kidney transplant recipients
por: Rosenborg, Staffan, et al.
Publicado: (2014)

Predicting donor, recipient and graft survival in living donor kidney transplantation to inform pretransplant counselling: the donor and recipient linked iPREDICTLIVING tool – a retrospective study
por: Haller, Maria C., et al.
Publicado: (2020)

Cellular and molecular immune profiles in renal transplant recipients after conversion from Tacrolimus to Sirolimus
por: Gallon, Lorenzo, et al.
Publicado: (2014)

Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients
por: Robertsen, Ida, et al.
Publicado: (2013)

HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival
por: Younas, Nizar, et al.
Publicado: (2010)

Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients
por: Sunder-Plassmann, Gere, et al.
Publicado: (2012)

Randomized Trial of Ciclosporin with 2-h Monitoring vs. Tacrolimus with Trough Monitoring in Liver Transplantation: DELTA Study
por: Ruijter, Bastian N., et al.
Publicado: (2023)

Conversion from twice- to once-daily tacrolimus in pediatric kidney recipients: a pharmacokinetic and bioequivalence study
por: Lapeyraque, Anne-Laure, et al.
Publicado: (2014)

Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients
por: Handisurya, Ammon, et al.
Publicado: (2016)

Low Transfer of Tacrolimus and Its Metabolites into Colostrum of Graft Recipient Mothers
por: Kociszewska-Najman, Bozena, et al.
Publicado: (2018)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Publisher Correction: Re-estimation improved the performance of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis
por: Wallisch, Christine, et al.
Publicado: (2020)

Re-estimation improved the performance of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis
por: Wallisch, Christine, et al.
Publicado: (2020)

Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT): A Phase 2 Trial of Stable Renal Transplant Recipients
por: Gaber, A. Osama, et al.
Publicado: (2013)

Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function
por: Han, Seung Seok, et al.
Publicado: (2016)

Epidemiology of Uromodulin-Associated Kidney Disease – Results from a Nation-Wide Survey
por: Lhotta, Karl, et al.
Publicado: (2012)

Ciclosporin 10 years on: indications and efficacy
por: Forsythe, Peter, et al.
Publicado: (2014)

Ciclosporin: Various toxicities: case report
Publicado: (2022)

Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor(®) EL
por: Ehinger, Karl Henrik Johannes, et al.
Publicado: (2012)

A Prospective, Observational Study of Conversion From Immediate- to Prolonged-Release Tacrolimus in Renal Transplant Recipients in France: The OPALE Study
por: Moal, Valérie, et al.
Publicado: (2019)

A Single Lung Transplant in a Patient with Fabry Disease: Causality or Far-Fetched? A Case Report
por: Gaggl, Martina, et al.
Publicado: (2013)

Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination
por: Aigner, Christof, et al.
Publicado: (2023)

First case of atypical haemolytic uraemic syndrome following COVID-19 vaccination with BNT162b2
por: Schmidt, Sophie H, et al.
Publicado: (2022)

Erratum to: Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor(®) EL
por: Ehinger, Karl Henrik Johannes, et al.
Publicado: (2013)

Late onset tacrolimus-induced life-threatening polyneuropathy in a kidney transplant recipient patient
por: Renard, Delphine, et al.
Publicado: (2012)

Ciclosporin in canine dermatology: a decade of comfort
por: DeBoer, Douglas J.
Publicado: (2014)

Acitretin/ciclosporin: Treatment failure : case report
Publicado: (2021)

Ciclosporin/prednisone: Visceral leishmaniasis: case report
Publicado: (2022)

Impact of Electronic Health Record Interface Design on Unsafe Prescribing of Ciclosporin, Tacrolimus, and Diltiazem: Cohort Study in English National Health Service Primary Care
por: MacKenna, Brian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6775hh5fj04ao24erkfepjk0kc